BIOLOGICAL IMPLANTS - A MARKET INSIGHT REPORT

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Foreword

• Biological Implants - A Revolutionary Human Repair Technique
  • Segmentation of Biological Implants
    • Exhibit 1: Segmentation of Global Biological Implants Market by Tissue/Muscle (Orthopedic, Soft Tissue, Cardiovascular, and Other*), by Origin (Allograft and Xenograft) and by Mode of Administration (Surgical and Injectable)

2. Global Market Analysis

• Exhibit 2: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
• Medical Implants
  • An Overview of Medical Implants
  • History of Implants
  • The Need for a Better Implant
  • Naturally Derived Implants
  • Orbital Implants and Artificial Eyes
  • Artificial Skin
  • Hip Replacement
• Tissues
  • Animal Tissues
  • Plant Tissues
• Definitions
  • Implant
  • Transplant
  • Explant
  • Types of Implants
    • Artificial Implants
    • Biological Implants
  • Tissue Engineering
  • Market Analysis of Tissue/Muscle Biological Implants by Geographic Region
    • Orthopedic
      • Exhibit 3: Orthopedic Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 4: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 5: Soft Tissue Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 6: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 7: Cardiovascular Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 8: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 9: Biological Implants in Other Tissue/Muscle (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 10: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  • Market Analysis of Origin by Geographic Region
    • Allograft
      • Exhibit 11: Allograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 12: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Xenograft
      • Exhibit 13: Xenograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 14: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  • Market Analysis of Mode of Administration by Geographic Region
    • Surgical
      • Exhibit 15: Surgical Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 16: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Injectable
      • Exhibit 17: Injectable Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 18: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
      • Exhibit 19: List of Major Global Companies

3. Regional Market Analysis

• North America
  • Exhibit 20: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Major Companies in North America
    • Aastrom Biosciences, Inc. (USA)
    • Alphatec Spine, Inc. (USA)
    • CONMED Linvatec (USA)
    • CryoLife®, Inc. (USA)
    • Curis, Inc. (USA)
    • Exactech, Inc. (USA)
    • Fascia Biosystems LLC (USA)
    • Inamed Aesthetics (USA)
    • Integra Lifesciences Corporation (USA)
    • IOP, Inc. (USA)
    • LifeCell Corporation (USA)
    • Nuvasive, Inc (USA)
    • Organogenesis, Inc. (USA)
    • Osteotech, Inc. (USA)
    • Pegasus Biologics, Inc. (USA)
    • QLT Inc. (Canada)
    • Stryker Corporation (USA)
    • Tutogen Medical, Inc. (USA)
  • Market Analysis by Tissue / Muscle Biological Implants in North America
    • Ortopedic
      • Exhibit 21: Ortopedic Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 22: Ortopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • SoftTissue
      • Exhibit 23: SoftTissue Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 24: SoftTissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 25: Cardiovascular Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 26: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 27: Biological Implants in Other Tissue/Muscle (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 28: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  • Market Analysis by Origin in North America
    • Allograft
      • Exhibit 29: Allograft Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 30: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Xenograft
      • Exhibit 31: Xenograft Biological Implants (2005-2012) - North American Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 32: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Market Analysis by Mode of Administration in North America
    • Surgical
      • Exhibit 33: Surgical Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 34: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Injectable
      • Exhibit 35: Injectable Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 36: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  • Europe
  • Exhibit 37: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Major Companies in Europe
    • M Arthro Kinetics plc (UK)
    • Asterand Plc (UK)
    • AutoTissue GmbH (Germany)
    • BioTissue Technologies AG (Germany)
  • Market Analysis by Tissue / Muscle in Europe
    • Orthopedic
      • Exhibit 38: Orthopedic Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 39: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 40: Soft Tissue Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 41: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 42: Cardiovascular Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 43: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 44: Biological Implants in Other Tissue / Muscle(2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 45: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
  • Market Analysis by Origin in Europe
    • Allograft
      • Exhibit 46: Allograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 47: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Xenograft
      • Exhibit 48: Xenograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 49: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
  • Market Analysis by Mode of Administration in Europe
    • Surgical
      • Exhibit 50: Surgical Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 51: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Injectable
      • Exhibit 52: Injectable Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 53: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Asia-Pacific
      • Exhibit 54: Biological Implants (2005-2012) -Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Major Companies in Asia-Pacific
  • bioMD Limited (Australia)
  • Maxigen Biotech, Inc. (Taiwan)
  • Market Analysis by Tissue / Muscle in Asia-Pacific
    • Orthopedic
      • Exhibit 55: Orthopedic Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 56: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 57: Soft Tissue Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 58: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 59: Cardiovascular Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 60: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 61: Biological Implants in Other Tissue / Muscle (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 62: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
  • Market Analysis by Origin in Asia-Pacific
    • Allograft
      • Exhibit 63: Allograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 64: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Xenograft
      • Exhibit 65: Xenograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 66: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
  • Market Analysis by Mode of Administration in Asia-Pacific
    • Surgical
      • Exhibit 67: Surgical Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 68: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Injectable
      • Exhibit 69: Injectable Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 70: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Rest of World
      • Exhibit 71: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
  • Market Analysis by Tissue/Muscle in Rest of World
    • Orthopedic
      • Exhibit 72: Orthopedic Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 73: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 74: Soft Tissue Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 75: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 76: Cardiovascular Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 77: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 78: Biological Implants in Other Tissue / Muscle (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 79: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
  • Market Analysis by Origin in Rest of World
    • Allograft
      • Exhibit 80: Allograft Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 81: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Xenograft
      • Exhibit 82: Xenograft Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 83: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Market Analysis by Mode of Administration in Rest of World
    • Surgical
      • Exhibit 84: Surgical Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 85: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Injectable
      • Exhibit 86: Injectable Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 87: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

III. PRODUCT/TECHNOLOGY RESEARCH

1. Introduction

• Biological Implants Growth Trends - Global Markets
  • Exhibit 88: Global Market for Biological Implants: Geographic Regions (North America, Europe, Asia-Pacific, Rest of World) Ranked by Projected CAGR for 2005 through 2012(Graphical Representation Included)
• Types of Biological Implants
• Application Biological Implants
  • Function and Use of Biological Implants
  • Application of Biological Implants in ENT surgery
    • Location of the Bioimplant: Middle Ear
      • Ossicle Replacement Draws Mixed Response
      • Tympanoplasty
      • Traumatic Perforation Using Fibrin-coated Collagen
    • Location of the Bioimplant: Paranasal Sinuses and Cranial Bones
      • Orbital Wall Reconstructions Using Allogenic Materials
    • Location of the Bioimplant: Bone and Cartilage of the Nose
      • Allogenic Materials to Develop Cartilage
      • Septal Abscess
      • Soft Tissue Implants
    • Location of the Bioimplant: Base of the Skull
      • Allogenic Materials to Treat Dural Defects
      • Allogenic Materials Required to Accomplish Duraplasty
      • The Application of Fibrin Glues in ENT Surgeries
    • Location of the Bioimplant: Trachea/Larynx
      • The Replacement of Trachea Using Solvent-preserved Allogenic Variety of Trachea
      • The Various Disorders of Vocal Cord
    • Location of the Bioimplant: Skin
      • The Process of Skin Replacement
      • Wrinkle Lift Treatment

2. Segmentation of Biological Implants

• Segmentation by Tissue/Muscle
  • Growth Trends - Global Market for Biological Implants by Tissue /Muscle
    • Exhibit 89: Global Market for Biological Implants by Tissue / Muscle (Other, Soft Tissue, Orthopedic, and Cardiovascular) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Soft Tissue Biological Implants
  • Growth Trends - Global Market for Soft Tissue Biological Implants
    • Exhibit 90: Global Market for Soft Tissue Biological Implants: Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Biological Implants in Cosmetic Surgery
  • Lip Augmentation Using Bioimplants
  • Allograft Implants Used in Lip Augmentation
  • Types and Characteristics of Various Allograft Implants
    • Alloderm
    • Apligraft
    • Cosmoderm 1 & 2
    • Cosmoplast
    • Cymetra or Micronized Alloderm
    • Fascian
  • Surgisis Soft Tissue Graft & Surgisis ES Soft Tissue Graft
  • Self Derived [Autologous] Implants & Injectables
  • Types and Characteristics of Autologous Implants
    • Autologen
    • Dermis Grafts
    • Dermis Fat Grafts
    • Fascia Grafts
    • Fat Grafting, Transfer or Transplanting
    • Isolagen
    • Scar Tissue Grafting
    • Tendon Grafting
• Cosmetic Surgery
  • Global Market Analysis for Cosmetic Surgery
    • Exhibit 91: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    • Exhibit 92: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) for Cosmetic Surgery in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
    • Exhibit 93: Cosmetic Surgery (2006, 2009 and 2012) - Percentage Breakdown for Cosmetic Surgery in US, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
  • Orthopedic Biological Implants
    • Growth Trends - Global Market for Orthopedic Biological Implants
      • Exhibit 94: Global Market for Orthopedic Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
      • Bone Graft Substitutes
      • Osteoinductive Agents - Substitute for Bone Allografts
      • Fibrin Matrix
  • Cardiovascular Biological Implants
    • Growth Trends - Global Market for Cardiovascular Biological Implants
      • Exhibit 95: Global Market for Cardiovascular Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Other (Dental, Ophthalmic, Urologic)
    • Growth Trends - Global Market for Biological Implants in Other Tissue/Muscle
      • Exhibit 96: Global Market for Biological Implants in other Tissue/Muscle: Geographic Region (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
      • Other Tissue/Muscle Biological Implant Products
      • Ophthalmic Biological Implants

3. Segmentation by Origin of Biological Implants

• Growth Trends - Global Market for Biological Implants by Origin
  • Exhibit 97: Global Market for Biological Implants by Origin (Xenograft, Alloraft) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Allograft and Xenograft Biological Implants
  • Autografts and their Limitations
  • Utilization of the Allograft Bone Tissue
  • Limitations of the Process
• Few Disadvantages of Using Allografts
• Preventive Measures for Warding Infection
• Bone Grafting
  • Xenografts
  • Using Valved Porcine Xenografts in the Right Ventricle Outlet for Congenital Anomalies
  • Other Avenues of Research
  • The L-Hydro Method
• Allograft Biological Implants
  • Growth Trends - Global Market for Allograft Biological Implants
    • Exhibit 98: Global Market for Allograft Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Xenograft Biological Implants
  • Growth Trends - Global Market for Xenograft Biological Implants
    • Exhibit 99: Global Market for Xenograft Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
    • Allograft Bone Tissue - Processing
      • Preparation for Biotransplantation
    • Allograft Bone Tissue
    • Base Tissue Segment
      • The Processing of Allograft Bone Tissue
      • Processing of Grafton® DBM - A Biological Implant Product of Osteotech
    • CXC Technology
      • The Process of Tissue Processing Using Tutogen
      • The Process of Manufacture and Processing of Allografts
• Stentless Porcine Xenograft (Mitral Valve Replacement)

4. Segmentation by Mode of Administration

• Growth Trends - Global Market for Biological Implants by Mode of Administration
  • Exhibit 100: Global Market for Biological Implants by Mode of Administration (Injectable and Surgical) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Injectable Biological Implants
  • Growth Trends - Global Market for Injectable Biological Implants
    • Exhibit 101: Global Market for Biological Implants by Mode of Administration : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Injectable Fillers for Soft Tissue Augmentation
    • Types of Augmentation Materials
  • Osteogenic Injectable Bone Substitutes
• Surgical Biological Implants
  • Growth Trends - Global Market for Surgical Biological Implants
    • Exhibit 102: Global Market for Surgical Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

5. Product Trends

• Research and Development
  • Neovascularisation Promoting Membrane for Biological Implants
  • Biological Implants of Semipermeable Amphiphilic Membranes
  • Artificial Tissue Systems
  • Stem Cells in Biological Implants
    • The Journey of Embryonic Stem Cells from Fundamental Biology to Medicine
    • Application of Umbilical Cord Lining Cells as Therapeutic Bioimplants for Metabolic Disorders
  • Drug Delivery and Smart Biological Implants
  • Tissue Engineered Biological Implants
  • Biological Implants Treatment of Vocal Fold Disorders
  • Systemic Inhibition of Tumor Growth using Biological Implants
    • Process of Secretion and Expression of TSP-2 using Polymer-Cell Grafts in Vivo
    • Inhibition of Tumor Growth in Mice Containing TSP-2-secreting Bioimplants.
    • Inhibition of Tumor Angiogenesis in Mice Containing TSP-2-secreted Bioimplants
  • Surgery for Valvular Heart Disease
  • RVOT Reconstruction
    • Bovine Valved Venous Xenografts for RVOT Reconstruction
  • Alloplastic Implants for Treatment of Stress Urinary Incontinence
  • Repair of Cartilage Lesions
    • Repair of Cartilage Lesions Using Biological Implants - A Comparative Histological and Biomechanical Study in Goats
  • Cryopreservation of Human Ovarian Tissues
  • ADAPT (Advanced Tissue Process) - CXC Technology
• Clinical Trials
  • Man Implanted with Teeth obtained from shoulder!!!!
  • Implantation of Esterified Hyaluronic Acid in Microdissected Reinke' s Space
    • Healing of Brain and Bones
    • Saving Brain and Spines
    • The Perfect Knee
    • Get the Smile Back on Your Face
    • Mending Broken Hearts
• Biological Implants in Sports Medicine
  • Allografts in Sports
• Transplantation Genetics
  • Acceptance of Biological Implants
• Biphasic Implants
  • Preparation of a Biphasic Scaffold
  • Devising Biological Implants for Healing of Joint Disorders
• Biomaterials
  • The Construction of New Body Parts
  • Orthopedic Biomaterials
  • Heart Valve Biomaterials
• Risk of Infection, Off - Label Use and Safety
  • Table: Different Processes Used for Preservation of Allografts and Xenografts
• Ethical Issues Concerning Biological Implants
  • Moral Issue and Balancing Concept
    • Animal Rights
      • “Speciesism”
      • Rights
      • Objectivity
    • Practical Issue
  • Animal-to-Human Transplantation

IV. MARKET DYNAMICS

1. Market Overview

• Global Market Analysis for Implants
  • Exhibit 103: Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
• Global Market Analysis for Spinal Implants
  • Exhibit 104: Spinal Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 105: Spinal Implants (2005-2012) - Global Market Analysis (Current & Future) for Implants in US, Europe, Asia, Canada and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 106: Spinal Implants (2006, 2009 and 2012) - Percentage Breakdown for Implants in USA, Europe, Asia-Pacific, Canada and Rest of World (Graphical Representation Included)
• Global Market Analysis for Orthopedic Implants
  • Exhibit 107: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 108: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) for Orthopedic Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 109: Orthopedic Implants (2006, 2009 and 2012) - Percentage Breakdown for Orthopedic Implants in USA, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
• Global Market Analysis for Cardiovascular Implants
  • Exhibit 110: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 111: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current & Future) for Cardiovascular Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 112: Cardiovascular Implants (2006, 2009 and 2012) - Percentage Breakdown for Cardiovascular Implants in USA, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
• Global Market Analysis for Dental Implants
  • Exhibit 113: Dental Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 114: Dental Implants (2005-2012) - Global Market Analysis (Current & Future) for Dental Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 115: Dental Implants (2006, 2009 and 2012) - Percentage Breakdown for Dental Implants in US, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
• Global Market Analysis for Biological Implants
  • Exhibit 116: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million (Graphical Representation Included)
  • Exhibit 117: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
• Global Market Analysis by Tissue/Muscle
  • Exhibit 118: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
  • Exhibit 119: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)
• Global Market Analysis by Origin
  • Exhibit 120: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
  • Exhibit 121: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Origin for Allograft and Xenograft
• Global Market Analysis by Mode of Administration
  • Exhibit 122: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
  • Exhibit 123: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

2. Market Trends

3. Major Companies in Biological Implants Industry

• Aastrom Biosciences, Inc. (USA)
• Alphatec Spine, Inc. (USA)
• Arthro-Kinetics Plc (UK)
• Asterand Plc (UK)
• AutoTissue GmbH (Germany)
• bioMD Limited (Australia)
• BioTissue Technologies AG (Germany)
• CONMED Linvatec (USA)
• CryoLife, Inc. (USA)
• Curis, Inc. (USA)
• Exactech, Inc. (USA)
• Fascia Biosystems LLC (USA)
• Inamed Aesthetics (USA)
• Inion OY (Finland)
• Integra Lifesciences Corporation (USA)
• IOP, Inc. (USA)
• LifeCell Corporation (USA)
• Maxigen Biotech, Inc. (Taiwan)
• NuVasive Inc. (USA)
• Organogenesis, Inc. (USA)
• Osteotech, Inc. (USA)
• Pegasus Biologics, Inc. (USA)
• QLT, Inc. (Canada)
• Stryker Corporation (USA)
• Tutogen Medical, Inc. (USA)

4. Major Activities in Biological Implants Industry

• Organogenesis Inc. Signs MoU with National Tissue Engineering Center of China
• Tutogen Medical, Inc. Signs New Tissue Supply Agreement and Extends Existing Agreement
• Regeneration Technologies Merges with Tutogen Medical
• Integra Creates a New Global Leader in Orthobiologics with New Acquisition (IsoTis)
• Osteotech Signs Tissue Supply Agreement with LifeNet Health
• RTI Introduces New BioCleanse® Meniscus
• Mentor Launches New NeoForm™ Dermis for Breast Reconstruction
• LifeCell Corporation Receives 510(k) Clearance for New Soft Tissue Repair Product
• RTI Signs Distribution and Supply Agreement with Stryker Corporation
• Inion Granted with US Patent for Bioactive Materials Technology
• Tutogen Medical Signs an International Distribution Agreement with Coloplast Corporation
• Osteotech and Novation sign Single Source Agreement
• Aastrom' s IND Phase III bags FDA approval for Treating Osteonecrosis of the Femoral Head
• ACT Uses Hemangioblasts to Reduce the Risk of Heart Attack
• IsoTis Expands Existing Private Label Agreement with AlloSource for First Generation DBM Products
• RTI Signs Ten Year Distribution Agreement with Zimmer Holdings for New Allograft Paste Implant
• Tutogen Medical Inc. Signs Distribution Agreement with Zimmer Holdings Inc
• Alphatec Holdings Acquires Technology License for Minimally Invasive Spinal Surgery
• Japanese Ministry Endorses Alphatec' s NOVEL Titanium Product Family
• FDA Approval to Exactech for Distribution of Equinox® Reverse Shoulder
• U.S. FDA Grants 510(k) Clearance to Osteotech for Plexur™ P
• Advanced Cell Technology Buys Technology Assets of Infigen
• Bone Regeneration Phase II Clinical Trials Initiated by Kuros
• FDA grants Orphan Drug Designation to Kuros' New Bone Repair Product
• Inion Product Range of BMI Widens with the Approval of ANCHRON™ in Europe
• NuVasive Buys Biologic Product Platform
• License Agreements between Alphatec and Scient' x for Manufacture and Distribution of Spine Implants
• University of Rochester and StemCapture Unveil an Anticancer Stem Cell Implant Device.
• Musculoskeletal Transplant Foundation Announces Three Year Deal with Affinergy
• Bioheart Inc. Expands Clinical Trials of Adult Myogenic Stem Cells
• Encore Medical Acquires Cefar AB of Sweden
• Pegasus Biologics' Wound Dressing Receives FDA Approval
• CryoLife Enters into Alliance with Bioform Medical for Development and Marketing of BioGlue®
• Stem Cell Innovations Enters into Collaboration with ND TWente University for Assessment of Bone Forming Capability of Pluricells
• Exactech Gains FDA Clearance for DBM with Bone Chips, OptecureTM +CCC
• Affinergy Signs Development Agreement with Synthes
• Affinergy Joins Hands with DuPont for New Bio-based Materials
• Acquisition of Exclusive Option Rights of Cell Technology by Bioheart
• Axordia Enters into Collaboration with Lombard Medical Technologies for Developing of Therapy for Coronary Artery Disease
• Smith & Nephew Buys OsteoBiologics Inc.
• Acologix Announces Findings of the Initial Feasibility Study of AC-100
• Bone Growth Stimulator - New Product of Alphatec Holdings.
• Exactech Adds Cemented Stem to its Hip System
• Avecia Given £1m Grant to Develop Bioprocessing Technology for Generating Synthetic Skin for Burn Victims
• Patent Licensing Agreement Signed between Bioheart and Tricardia
• Inion' s Novel Bioactive Technology Granted with US Patent
• Cytori Reveals Outcome of Adipose-derived Stem Cell Therapy
• Alphatec Spine and OsteoBiologics Enter into an Agreement for Distribution of Spine Products.
• Bioheart Signs Agreement to Use Cleveland Clinic' s Proprietary Methods
• Pegasus Launches OrthADAPT™ Bioimplant - a Revolutionary New Biologic Scaffold for Orthopedic Soft Tissue Reinforcement
• Cambrex Buys Cutanogen Corporation
• Inion Enters into Alliance with Aesculap for Distribution of its Spinal Product Range Across the US and Canada
• Inion Enters into an Agreement with the University of Cambridge for Advancement of Bioactive Products
• Total ReCord Initiates Novel treatment for Spinal Cord Injuries
• Inion and Richard Wolf Medical Instruments Enter into Agreement for Distribution of Sports Medicine
• International Distribution Agreement Signed by OsteoBiologics and CONMED Linvatec for Cartilage and Bone Repair Product Range
• Millenium Biologix Enters into License Agreement Exclusively to Improve ACTES(TM)-C
• Inion Launches Biodegradable Spinal Implant in the EU
• OsteoBiologics Enters into Collaboration with Nexa Orthopedics for Surgical Extremities
• Affinergy Awarded SBIR Grant for Research on Medical Device Materials
• Genzyme Acquires Verigen AG
• CryoLife and Endologix Enter into a Development Agreement for BioFoam

5. Regional Market Analysis

• A. NORTH AMERICA
  • Market Analysis
    • Exhibit 124: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 125: List of Major Companies in North America
  • Market Analysis by Geographic Region
    • Exhibit 126: Biological Implants (2005-2012) -North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
    • Exhibit 127: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 128: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 129: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular, and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 130: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 131: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 132: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 133: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • North American Biological Implants Market By Country
• A1. United States
  • United States Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 134: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 135: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the US Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 136: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 137: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of US Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 138: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 139: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of US Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• A2. Canada
  • Canadian Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 140: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 141: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 142: Biological Implants (2005-2012) - Canadian Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 143: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 144: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 145: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B. EUROPE
  • Market Analysis
    • Exhibit 146: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 147: List of Major Companies in Europe
  • Market Analysis by Geographic Region
    • Exhibit 148: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
    • Exhibit 149: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 150: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 151: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular, and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 152: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 153: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 154: Biological Implants (2005-2012) -European Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 155: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • European Biological Implants Market By Country
• B1. Germany
  • German Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 156: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 157: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 158: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 159: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 160: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 161: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B2. The United Kingdom
  • UK Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 162: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million
      • Exhibit 163: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 164: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 165: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 166: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 167: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B3. France
  • French Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 168: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 169: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 170: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million(Graphical Representation Included)
      • Exhibit 171: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 172: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 173: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B4. Switzerland
  • Swiss Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 174: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 175: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)
    • Analysis by Origin
      • Exhibit 176: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 177: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 178: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 179: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B5. Rest of Europe
  • Rest of Europe Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 180: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 181: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Tissue/Muscle for Soft Tissue, Orthopedic, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 182: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 183: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 184: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 185: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• C. ASIA-PACIFIC
  • Market Analysis
    • Exhibit 186: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 187: List of Major Companies in Asia-Pacific
  • Analysis by Geographic Region
    • Exhibit 188: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    • Exhibit 189: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 190: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 191: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Tissue/Muscle for Orthopedic, Soft tissue, Cardiovascular and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 192: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 193: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 194: Biological Implants (2005-2012) -Asia-Pacific Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 195: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • Asia-Pacific Biological Implants Market By Country
• C.1. Australia
  • Australian Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 196: Biological Implants (2005-2012) - Australian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 197: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 198: Biological Implants (2005-2012) - Australian Market Analysis o(Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 199: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 200: Biological Implants (2005-2012) -Australian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 201: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• C2. Japan
  • Japanese Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 202: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 203: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 204: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 205: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 206: Biological Implants (2005-2012) -Japanese Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 207: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• C3. Rest of Asia-Pacific
  • Rest of Asia-Pacific Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 208: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 209: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 210: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 211: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 212: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 213: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• D. REST OF WORLD
  • Market Analysis
    • Exhibit 214: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 215: List of Major Companies in Rest of World
  • Analysis by Geographic Region
    • Exhibit 216: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of *World in US$ Million (Graphical Representation Included)
    • Exhibit 217: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 218: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 219: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 220: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 221: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 222: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 223: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • Rest of World Biological Implants Market By Country
• D1. Israel
  • Israeli Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 224: Biological Implants (2005-2012) - Israeli Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 225: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 226: Biological Implants (2005-2012) -Israeli Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 227: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 228: Biological Implants (2005-2012) -Israeli Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 229: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• D2.Brazil
  • Brazilian Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 230: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 231: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 232: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 233: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 234: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 235: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• D3. Rest of World (Excluding Israel and Brazil)
  • Rest of World Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 236: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 237: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Tissue/Muscle for Soft Tissue, Orthopedic, Cardiovascular and Other (Graphical Representation Included)
    • Analysis by Origin
      • Exhibit 238: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 239: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 240: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 241: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

6. Biological Implants - The Industry Outlook

V. CORPORATE DIRECTORY